IQI
ADMA icon

Integrated Quantitative Investments’s ADMA Biologics ADMA Stock Holding History

Integrated Quantitative Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,266
Closed -$1.33M – 280
2024
Q4 		$1.33M Buy
+77,266
New +$1.45M 0.65% 31

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Integrated Quantitative Investments's ADMA Position: Q1 2025 in Review

Integrated Quantitative Investments sold out of ADMA Biologics (ADMA) in Q1 2025, closing a stake of 77,266 shares — an estimated $1.33M sold.

Integrated Quantitative Investments first reported a position in ADMA in Q4 2024 and held it in 1 quarter. The position peaked at $1.33M in Q4 2024. 347 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

  • Integrated Quantitative Investments reported no remaining ADMA Biologics position as of Q1 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 77,266 ADMA Biologics shares in Q1 2025, an estimated $1.33M.
  • Integrated Quantitative Investments first reported a position in ADMA Biologics in Q4 2024 and held it in 1 quarter.
  • Integrated Quantitative Investments's ADMA Biologics position peaked at $1.33M in Q4 2024.
  • 347 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on Integrated Quantitative Investments's 13F filing for Q1 2025, filed 15 May 2025.